Protective effects of azelaic acid against high-fat diet-induced oxidative stress in liver, kidney and heart of C57BL/6J mice

Molecular and Cellular Biochemistry

Volumn 377, Issue 1-2, 2013, Pages 23-33

  Muthulakshmi, Shanmugam ^a   Saravanan, Ramalingam ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Azelaic acid; Enzymatic antioxidant; High fat diet; Lipid peroxidation; Non enzymatic antioxidant

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZELAIC ACID; CREATININE; GLUCOSE; GLUTATHIONE; GLUTATHIONE REDUCTASE; INSULIN; ROSIGLITAZONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UREA; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET RESTRICTION; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; KIDNEY; LIPID DIET; LIPID PEROXIDATION; LIVER; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; DICARBOXYLIC ACIDS; DIET, HIGH-FAT; EATING; ERYTHROCYTES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HEART; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MYOCARDIUM; OXIDATIVE STRESS; THIAZOLIDINEDIONES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES; VITAMIN E;

MUS;

EID: 84875673545     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1566-1     Document Type: Article

References (57)

1. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Nakajima Y, Nakayama O (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Investig 114:1752-1761
2. Buettner R, Scholmerich J, Bollheimer LC (2007) High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 15:798-808
3. Mathur A, Marine M, Lu D, Swartz-Basile DA, Saxena R, Zyromski NJ, Pitt HA (2007) Nonalcoholic fatty pancreas disease. HPB (Oxford) 9:312-318
4. Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H (2008) Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Met Clin Exp 57:1071-1077
5. Reaven G, Abbasi F, McLaughlin T (2004) Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 59:207-223
6. Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P (2002) Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 75:767-772
7. Olusi SO (2002) Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotecticve enzymes in humans. Int J Obes 26:1159-1164
8. Fraulob JC, Diamantino RO, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA (2010) A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 46:212-223
9. Nissen SE, Wolski K (2010) Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med 26:1191-1201
10. Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ (2009) Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, openlabel trial. Lancet 373:2125-2135
11. Anderson JW, Hanna TJ, Peng X, Kryscio RJ (2000) Whole grain foods and heart disease risk. J Am Coll Nutr 19:291S-299S
12. Montonen J, Knekt P, Jarvinen R, Aromaa A, Reunanen A (2007) Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 77:622-629
13. Munter JS, Hu FB, Spiegelman D, Franz M, Dam RMV (2007) Whole grain, bran and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 4:e261
14. Mehmood S, Orhan I, Ahsan Z, Aslan S, Gulfraz M (2008) Fatty acid composition of seed oil of different Sorghum bicolor varieties. Food Chem 109:855-859
15. Marsden JR, Shuster S (1983) The effect of azelaic acid on acne. Br J Dermatol 109:723-725
16. Breathnach AS (1999) Azelaic acid: potential as a general antitumoural agent. Med Hypotheses 52:221-226
17. Charnock C, Brudeli B, Klaveness J (2004) Evaluation of the antibacterial efficacy of diesters of azelaic acid. Eur J Pharm Sci 21:589-596
18. Nguyen QH, Bui TP (1995) Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol 34:75-84
19. Mastrofrancesco A, Ottaviani M, Aspite N (2010) Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPAR gamma activation. Exp Dermatol 19:813-820
20. Trinder P (1969) Determination of blood glucose using an oxidase peroxidase system with a non carcinogenic chromogen. J Clin Pathol 22:158-161
21. Burgi W, Briner M, Franken N, Kessler ACH (1998) One step sandwich enzyme immunoassay for insulin using monoclonal antibodies. Clin Biochem 213:11-314
22. Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamate oxaloacetic and glutamate pyruvic transaminases. Am J Clin Pathol 28:56-63
23. Kind PR, King EJ (1954) Estimation of plasma phosphatase by determination of hydrolyzed phenol with amino-antipyrine. J Clin Pathol 7:322-326
24. Fawcett JK, Scott JE (1960) A rapid and precise method for the determination of urea. J Clin Path 3:156-159
25. Caraway WT (1955) Determination of uric acid in serum by carbonate method. Am J Clin Path 25:840-845
26. Kakkar P, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 21:130-132
27. Sinha AK (1972) Colorimetric assay of catalase. Anal Biochem 47:389-394
28. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidise. Science 179:588-590
29. Habig WH, Pabst MJ, Jakoby WBC (1974) Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem 249(22):7130-7139
30. Pinto RE, Bartley W (1969) The effect of age and sex on glutathione reductase and glutathione peroxidase activities on aerobic glutathione oxidation in rat liver homogenate. Biochem J 12:109-115
31. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77
32. Roe JH, Kuether CA (1943) The determination of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenylhydrazine derivative of dehydroascorbic acid. J Biol Chem 11:145-164
33. Baker H, Frank O, DeAngelis B, Feingold S (1980) Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Res 21:531-536
34. Niehaus WG, Samuelsson B (1968) Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6:126-130
35. Jiang ZY, Hunt JV, Wolff SP (1992) Ferrous ion oxidation in the presence of xylenol orange for the detection of lipid hydroperoxides in low density lipoprotein. Anal Biochem 202:384-389
36. Surwit RS, Feinglos MN, Rodin J (1995) Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44:645-651
37. Mei J, Yu S, Ahren B (2010) Study on administration of 1,5-anhydro-d-fructose in C57BL/6J mice challenged with high-fat diet. BMC Endocr Disord 10(17):1-5
38. Kim MR, Park Y, Albright KJ, Pariza MW (2002) Differential responses of hamsters and rats fed high-fat or low-fat diets supplemented with conjugated linoleic acid. Nutr Res 22:715-722
39. Gallou-Kabani Vige A, Gross MS (2007) C57BL/6J and A/J mice fed a high fat diet delineate components of metabolic syndrome. Obesity 15:1996-2005
40. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RA, Bogardus C et al (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:1889-1895
41. Myers VC, Fine MS (1918) Comparative distribution of urea, creatinine, uric acid and sugar in the blood and spinal fluid. Am J Med Sci 76:239-244
42. Moron MS, Dipierre JW, Mannervik B (1979) Levels of glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 582(1):67-68
43. Halliwell B, Gutteridge JMC (1990) Role of free radicals and catalytic metal ions in human disease. Methods Enzymol 186:1-85
44. Ingold KU, Webb AC, Witter D, Burton GW, Metcalf TA, Muller DP (1987) Vitamin E remains the major lipid soluble, chain breaking antioxidant in human plasma even in individuals suffering from severe vitamin E deficiency. Arch Biochem Biophys 259(1):224-225
45. Packer L, Tritschler HJ, Wessel K (1997) Neuroprotection by metabolic antioxidant alpha lipoic acid. Free Radic Biol Med 22(1-2):359-378
46. Freisleben HJ, Packer L (1993) Free-radical scavenging activities, interactions and recycling of antioxidants. Biochem Soc Trans 21(2):325-330
47. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51-88
48. Cathcart RF (1985) Vitamin C: the nontoxic, nonrate-limited, antioxidant free radical scavenger. Med Hypotheses 18(1):61-77
49. Godin DV, Wohaieb SA, Garnett ME, Goumeniouk AD (1988) Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 84:223-231
50. Baynes JW (1991) Perspectives in diabetes: role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412
51. Rizvi SI, Maurya PK (2007) Markers of oxidative stress in erythrocytes during aging in humans. Ann N Y Acad Sci 1100:373-382
52. Haggai MC, Nieto N (2005) A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 19:136-138
53. Agarwal R, Vasavada N, Sachs NG, Chase S (2004) Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int 65:2279-2289
54. Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Kanasaki M (2007) Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol 18:2715-2723
55. Bournoville ML, Conti M, Bazin R, Michel O, Bariéty J, Chevalier J (1999) Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats. Nephrol Dial Transpl 15(4):467-476
56. Vincent HK, Powers SK, Dirks AJ, Scarpace P (2001) Mechanism for obesity induced increase in myocardial lipid peroxidation. Int J Obes 25:378-388
57. Esterbauer H, Gebicki J, Puhl H, Jurgens G (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol Med 13:341-390